We are live on ! Find out more
OYST

Oyster Point Pharma, Inc. Common Stock
OYST

Delisted

OYST was delisted on the 30th of December, 2022.

Back to rankings

61 hedge funds and large institutions have $336M invested in Oyster Point Pharma, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 17 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more funds holding in top 10

Funds holding in top 10: 3 → 5 (+2)

13% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 8

2% more funds holding

Funds holding: 60 → 61 (+1)

1% more capital invested

Capital invested by funds: $331M → $336M (+$4.75M)

6% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 17

Holders
61
Holders Change
+1
Holders Change %
+1.67%
% of All Funds
1.07%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.09%
New
9
Increased
16
Reduced
17
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$15.3M
2
BlackRock
BlackRock
New York
+$4.9M
3
First Manhattan
First Manhattan
New York
+$4.02M
4
GKIM
GW&K Investment Management
Massachusetts
+$1.08M
5
JP Morgan Chase
JP Morgan Chase
New York
+$1.01M

Top Sellers

Rank Fund Capital Flow
1
EA
Emerald Advisers
Pennsylvania
-$5.49M
2
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
-$2.23M
3
RI
RTW Investments
New York
-$1.35M
4
Citadel Advisors
Citadel Advisors
Florida
-$1.05M
5
Millennium Management
Millennium Management
New York
-$998K
Name Holding Trade Value Shares
Change 		Change in
Stake
WCM
26
Wildcat Capital Management
New York
$664K – – –
HP
27
Harbourvest Partners
Massachusetts
$625K +$717K +34,185 New
LP
28
Lexington Partners
New York
$501K +$575K +27,408 New
AA
29
AlphaCentric Advisors
Puerto Rico
$402K +$210K +10,000 +83%
Alyeska Investment Group
30
Alyeska Investment Group
Illinois
$400K – – –
ASP
31
Adams Street Partners
Illinois
$395K +$453K +21,625 New
Bank of New York Mellon
32
Bank of New York Mellon
New York
$385K -$42K -2,001 -9%
Goldman Sachs
33
Goldman Sachs
New York
$371K +$48.2K +2,298 +13%
Jacobs Levy Equity Management
34
Jacobs Levy Equity Management
New Jersey
$362K +$416K +19,830 New
VEA
35
Virtus ETF Advisers
New York
$274K +$5.58K +266 +2%
AllianceBernstein
36
AllianceBernstein
Tennessee
$250K -$21K -1,000 -7%
ECM
37
ExodusPoint Capital Management
New York
$245K +$281K +13,377 New
HLA
38
Hamilton Lane Advisors
Pennsylvania
$211K +$242K +11,521 New
California Public Employees Retirement System
39
California Public Employees Retirement System
California
$196K -$22.6K -1,079 -9%
HighTower Advisors
40
HighTower Advisors
Illinois
$187K -$446K -21,280 -68%
NL
41
NWAM LLC
Washington
$183K – – –
California State Teachers Retirement System (CalSTRS)
42
California State Teachers Retirement System (CalSTRS)
California
$168K – – –
HTC
43
Hershey Trust Company
Pennsylvania
$162K +$186K +8,861 New
CFGS
44
Concourse Financial Group Securities
Alabama
$133K – – –
Bank of America
45
Bank of America
North Carolina
$96K +$12.4K +592 +13%
New York State Common Retirement Fund
46
New York State Common Retirement Fund
New York
$95K – – –
SG
47
StepStone Group
California
$82K +$93.5K +4,461 New
Deutsche Bank
48
Deutsche Bank
Germany
$73K -$10.6K -504 -11%
Wells Fargo
49
Wells Fargo
California
$34K -$232K -11,076 -85%
UBS Group
50
UBS Group
Switzerland
$30K -$398 -19 -1%
1
2
3

OYST Hedge Fund Activity: Q1 2021 in Review

61 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Oyster Point Pharma, Inc. Common Stock (OYST) for Q1 2021, worth a combined $336M — up 1.4% from $331M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new OYST positions and 8 closed out — a net gain of 1 holder — while 16 added to existing stakes and 17 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $15.3M. The largest seller was Emerald Advisers, exiting entirely with an estimated $5.49M sold.

  • 61 institutional investors held Oyster Point Pharma, Inc. Common Stock (OYST) as of Q1 2021, up from 60 in Q4 2020.
  • Funds reported $336M of Oyster Point Pharma, Inc. Common Stock stock for Q1 2021, up 1.4% quarter-over-quarter.
  • 9 funds opened new Oyster Point Pharma, Inc. Common Stock positions in Q1 2021 and 8 closed out, a net change of +1 holder.
  • The largest Oyster Point Pharma, Inc. Common Stock buyer in Q1 2021 was Wellington Management Group, an estimated $15.3M added.
  • The largest Oyster Point Pharma, Inc. Common Stock seller in Q1 2021 was Emerald Advisers, an estimated $5.49M sold.

Based on aggregated 13F filings for Q1 2021.